This STEM ALPHA development was supported by ANVAR (Agence Nationale de la Valorisation pour la Recherche) / Oseo-BPI, Rhône-Alpes, France. Project N° A0303118V (Head of project : Daniel LICARI)

STEM ALPHA design and development

STEM ALPHA has designed and developed 26 prototypes, tested between 2001 and 2003

Objectives :

- to improve the quality of the delivered grafts - to reduce the loss of cornea by excessive endothelial cells loss at the end of conservation - to improve health safety (animal component free media)


The results obtained after use by cornea banks and patients follow-up confirmed the pre-clinical expected results.